World Business Dewpoint Therapeutics Teams Up with Merck to Evaluate Novel Approach for the Treatment of HIVBy Michael ChenJuly 14, 20200 Dewpoint Therapeutics, the biomolecular condensates company, announced today that it has forged an exclusive collaboration agreement with Merck (NYSE:MRK), known…
